Robotic Surgery: A Novel Approach for Breast Surgery and Reconstruction

医学 乳房再造术 乳腺癌 乳房切除术 机械人手术 外科 乳房外科 显微外科 乳房整形术 人口 普通外科 癌症 内科学 环境卫生
作者
Edward Donnely,Michelle Griffin,Peter E. M. Butler
出处
期刊:Plastic and reconstructive surgery. Global open [Ovid Technologies (Wolters Kluwer)]
卷期号:8 (1): e2578-e2578 被引量:32
标识
DOI:10.1097/gox.0000000000002578
摘要

Background: Breast cancer is the most prevalent cancer and second leading cause of cancer-related deaths in both the US and UK female population, a prominent cause of morbidity and cost to both health services. All surgically fit patients are offered breast reconstruction following the initial surgery, and this is traditionally an open approach: either implant-based or an autologous tissue flap. Both lead to scarring that is difficult to conceal. This paper aims to evaluate the novel minimally invasive technique of robotic-assisted surgery. Methods: A systematic review was conducted using Medline (OvidSP) and Embase (OvidSP) to evaluate the current application of robotic-assisted surgery in breast surgery and reconstruction. Results: Twenty-one articles were identified and discussed, composing of level 4 and 5 evidence comparing different surgeons' experiences, techniques, and outcomes. To date, the robotic system has been utilized to harvest the latissimus dorsi muscle for use as a tissue flap (total harvest time of 92 minutes), to perform nipple-sparing mastectomy with immediate breast reconstruction (total operation time 85 minutes) and lately to harvest a deep inferior epigastric perforator flap via an intraabdominal approach. Conclusions: Robotic-assisted surgery can successfully and reproducibly perform a nipple-sparing mastectomy with breast reconstruction. It can minimize the size of scarring and is superior to the laparoscopic technique, with improved 3-dimensional visualization, dexterity, and range of motion able to guide around the curvature of the breast. The main limiting factors are the lack of the US Food and Drug Administration approval, cost of the robot, and specialized skills required.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
充电宝应助无000采纳,获得10
1秒前
1秒前
艾亚完成签到,获得积分10
1秒前
raining发布了新的文献求助10
2秒前
3秒前
你好发布了新的文献求助10
3秒前
顺利紫山发布了新的文献求助10
3秒前
pluto应助HSMlala采纳,获得20
4秒前
MIN完成签到 ,获得积分10
5秒前
舒适路人发布了新的文献求助10
5秒前
英姑应助Fancy采纳,获得10
6秒前
7秒前
7秒前
7秒前
舟夏发布了新的文献求助30
7秒前
恸恸完成签到 ,获得积分10
8秒前
老实的斌完成签到,获得积分10
9秒前
ZXK完成签到 ,获得积分10
10秒前
new_yeah完成签到 ,获得积分10
11秒前
舒适路人发布了新的文献求助10
11秒前
Felix0917发布了新的文献求助10
12秒前
zwh完成签到,获得积分10
12秒前
小马甲应助英俊的流沙采纳,获得30
12秒前
12秒前
顺利紫山完成签到,获得积分10
13秒前
JamesPei应助奋斗的石头采纳,获得10
14秒前
昵称什么的不重要啦完成签到 ,获得积分10
14秒前
无极微光应助寒冷毛豆采纳,获得20
14秒前
19秒前
19秒前
烟花应助菜菜菜狗采纳,获得30
20秒前
君无双发布了新的文献求助30
22秒前
Fancy发布了新的文献求助10
25秒前
感动的涵菡完成签到,获得积分10
26秒前
26秒前
深情安青应助subathust采纳,获得10
26秒前
东皋发布了新的文献求助20
26秒前
奋斗的石头完成签到,获得积分20
27秒前
27秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Modern Epidemiology, Fourth Edition 5000
Handbook of pharmaceutical excipients, Ninth edition 5000
Digital Twins of Advanced Materials Processing 2000
Weaponeering, Fourth Edition – Two Volume SET 2000
Polymorphism and polytypism in crystals 1000
Signals, Systems, and Signal Processing 610
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 纳米技术 有机化学 生物化学 化学工程 物理 计算机科学 复合材料 内科学 催化作用 物理化学 光电子学 电极 冶金 基因 遗传学
热门帖子
关注 科研通微信公众号,转发送积分 6023090
求助须知:如何正确求助?哪些是违规求助? 7646777
关于积分的说明 16171357
捐赠科研通 5171450
什么是DOI,文献DOI怎么找? 2767125
邀请新用户注册赠送积分活动 1750492
关于科研通互助平台的介绍 1637045